West Pharmaceutical Services Inc (WST)
Net profit margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 492,700 | 593,400 | 585,900 | 661,800 | 346,200 |
| Revenue | US$ in thousands | 2,893,200 | 2,949,800 | 2,886,900 | 2,831,600 | 2,146,900 |
| Net profit margin | 17.03% | 20.12% | 20.30% | 23.37% | 16.13% |
December 31, 2024 calculation
Net profit margin = Net income ÷ Revenue
= $492,700K ÷ $2,893,200K
= 17.03%
West Pharmaceutical Services Inc's net profit margin has shown some fluctuations over the past five years. In December 2020, the net profit margin was 16.13%, which then increased to 23.37% by December 2021, indicating a significant improvement in profitability. However, in the following years, the net profit margin slightly decreased to 20.30% in December 2022 and further to 20.12% in December 2023. By December 2024, the net profit margin dropped to 17.03%, indicating a decrease in profitability compared to the previous years.
Overall, West Pharmaceutical Services Inc has managed to maintain a relatively healthy net profit margin above 15% during the period under review, indicating the company's ability to generate profits after accounting for all expenses. It is important for the company to closely monitor and manage its expenses and revenue streams to ensure sustained profitability in the future.
Peer comparison
Dec 31, 2024